Skip to main content
SpringerLink
Log in

Special Indications: Cirrhosis, Inflammatory Bowel Disease, and Organ Transplantation

  • Chapter
  • First Online:
The Perfect Sleeve Gastrectomy

  • 683 Accesses

Abstract

Laparoscopic sleeve gastrectomy (LSG) has gained popularity in the last years as the worldwide most accomplished bariatric procedure due to the striking results of sustained weight loss, improvement or remission of the main obesity comorbidities, and long-term improvement of the quality of life. The lower technical demand necessary for doing the procedure based in single upper abdominal approach and lack for gastrointestinal anastomosis usually requires shorter operative time, which can be very advantageous in patients with compromised health status. In addition, the absence of intestinal diversion keeping intact the intestinal absorption capacity may also be favorable to the sleeve in some situations. These advantages have already been widely demonstrated in general population with morbid obese, but the role of the LSG in patients with special conditions such as cirrhosis, inflammatory bowel disease, severe bowel adhesions, and in the setting of organ transplantation remains largely unreported.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lima M, Mourao S, Diniz M, et al. Hepatic histopathology of patients with morbid obesity submitted to gastric bypass. Obes Surg. 2005;15(5):661–9.

    Article  PubMed  Google Scholar 

  2. Esquivel CM, Garcia M, Armando L, et al. Laparoscopic sleeve gastrectomy resolves NAFLD: another formal indication for bariatric surgery? Obes Surg. 2018;28(12):4022–33.

    Article  PubMed  Google Scholar 

  3. Younossi ZM, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9:524–30.

    Article  PubMed  Google Scholar 

  4. Matteoni CA, Younossi ZM, Gramlich T, et al. Non-alcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116(6):1413–9.

    Article  CAS  PubMed  Google Scholar 

  5. Caldwell SH, Hespenheide EE. Sub-acute liver failure in obese women. Am J Gastroenterol. 2002;97:2058–62.

    Article  PubMed  Google Scholar 

  6. Shimada M, Hashimoto E, Tania M, et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol. 2002;37:154–60.

    Article  PubMed  Google Scholar 

  7. Hashizume H, Sato K, Takagi H, et al. Primary liver cancers with nonalcoholic steatohepatitis. Eur J Gastroenterol Hepatol. 2007;19:827–34.

    Article  PubMed  Google Scholar 

  8. Argo CK, Caldwell SH. Epidemiology and natural history of nonalcoholic steatohepatitis. Clin Liver Dis. 2009;13:511–31.

    Article  PubMed  Google Scholar 

  9. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37(4):917–23.

    Article  PubMed  Google Scholar 

  10. Subichin M, Clanton J, Makuszewski M, et al. Liver disease in the morbidly obese: a review of 1000 consecutive patients undergoing weight loss surgery. Surg Obes Relat Dis. 2015;11(1):137–41.

    Article  PubMed  Google Scholar 

  11. Verna EC, Berk PD. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Semin Liver Dis. 2008;28(4):407–26.

    Article  CAS  PubMed  Google Scholar 

  12. Schuppan Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371(9615):838–51.

    Article  PubMed  CAS  Google Scholar 

  13. Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749–61.

    Article  PubMed  Google Scholar 

  14. Singal AK, Salameh H, Kuo YF, et al. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation. 2013;95:755–60.

    Article  PubMed  Google Scholar 

  15. Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148:547–55.

    Article  PubMed  Google Scholar 

  16. Berzigotti A, Garcia-Tsao G, Bosch J, et al. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology. 2011;54(2):555–61.

    Article  PubMed  Google Scholar 

  17. Leoni S, Tovoli F, Napoli L, et al. Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis. World J Gastroenterol. 2018;24(30):3361–73.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.

    Article  PubMed  Google Scholar 

  19. Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28(12):3783–94.

    PubMed  Google Scholar 

  20. English WJ, DeMaria EJ, Brethauer SA, et al. American Society for Metabolic and Bariatric Surgery estimation of metabolic and bariatric procedures performed in the United States in 2016. Surg Obes Relat Dis. 2018;14(3):259–63.

    PubMed  Google Scholar 

  21. Dallal RM, Mattar SG, Lord JL, et al. Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg. 2004;14:47–53.

    Article  PubMed  Google Scholar 

  22. Dolce CJ, Russo M, Keller JE, et al. Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery. Surg Obes Relat Dis. 2009;5:323–8.

    Article  PubMed  Google Scholar 

  23. Brolin RE, Bradley LJ, Taliwal RV. Unsuspected cirrhosis discovered during elective obesity operations. Arch Surg. 1998;133:84–8.

    Article  CAS  PubMed  Google Scholar 

  24. Mummadi RR, Kasturi KS, Chennareddygari S, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6:1396–402.

    Article  PubMed  Google Scholar 

  25. Clanton J, Subichin M. The effects of metabolic surgery on fatty liver disease and nonalcoholic steatohepatitis. Surg Clin North Am. 2016;96:703–15.

    Article  PubMed  Google Scholar 

  26. Rizvon MK, Chou CL. Surgery in the patient with liver disease. Med Clin North Am. 2003;87:211–27.

    Article  PubMed  Google Scholar 

  27. Csikesz NG, Nguyen LN, Tseng JF, et al. Nationwide volume and mortality after elective surgery in cirrhotic patients. J Am Coll Surg. 2009;208:96–103.

    Article  PubMed  Google Scholar 

  28. Ziser A, Plevak DJ, Wiesner RH, et al. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology. 1999;90(1):42–53.

    Article  CAS  PubMed  Google Scholar 

  29. Millwala F, Nguyen GC, Thuluvath PJ. Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management. World J Gastroenterol. 2007;13(30):4056–63.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Garrison RN, Cryer HM, Howard DA, et al. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984;199:648–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Mansour A, Watson W, Shayani V, et al. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery. 1997;122:730–5.

    Article  CAS  PubMed  Google Scholar 

  32. Teh SH, Nagorney DM, Stevens SR, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007;132:1261–9.

    Article  PubMed  Google Scholar 

  33. Northup PG, Wanamaker RC, Lee VD, et al. Model for end-stage liver disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg. 2005;242:244–51.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Nicoll A. Surgical risk in patients with cirrhosis. J Gastroenterol Hepatol. 2012;27:1569–75.

    Article  PubMed  Google Scholar 

  35. Berzigotti A, Seijo S, Reverter E, et al. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7:141–55.

    Article  CAS  PubMed  Google Scholar 

  36. Nusrat S, Khan MS, Fazili J, et al. Cirrhosis and its complications: evidence based treatment. World J Gastroenterol. 2014;20:5442–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Kim JJ, Dasika NL, Yu E, et al. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery. J Clin Gastroenterol. 2009;43(6):574–9.

    Article  PubMed  Google Scholar 

  38. Hanipah ZN, Punchai S, McCullough A, et al. Bariatric surgery in patients with cirrhosis and portal hypertension. Obes Surg. 2018;28(11):3431–8.

    Article  PubMed  Google Scholar 

  39. Bruix J, Sherman M. Practice guidelines committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.

    Article  PubMed  Google Scholar 

  40. European Association for the Study of the Liver. European Organization for Research and Treatment of Cancer. EASLEORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–43.

    Article  Google Scholar 

  41. Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9:897–901.

    Article  PubMed  Google Scholar 

  42. Cobb WS, Heniford BT, Burns JM, et al. Cirrhosis is not a contraindication to laparoscopic surgery. Surg Endosc. 2005;19:418–23.

    Article  CAS  PubMed  Google Scholar 

  43. Chmielecki DK, Hagopian EJ, Kuo YH, et al. Laparoscopic cholecystectomy is the preferred approach in cirrhosis: a nationwide, population-based study. HPB (Oxford). 2012;14:848–53.

    Article  Google Scholar 

  44. Borbély Y, Juilland O, Altmeier J, et al. Perioperative outcome of laparoscopic sleeve gastrectomy for high-risk patients. Surg Obes Relat Dis. 2017;13:155–60.

    Article  PubMed  Google Scholar 

  45. Buchwald H, Lober PH, Varco RL. Liver biopsy findings in seventy-seven consecutive patients undergoing jejunoileal bypass for morbid obesity. Am J Surg. 1974;127:48–52.

    Article  CAS  PubMed  Google Scholar 

  46. Hocking MP, Duerson MC, O’Leary JP, et al. Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases. N Engl J Med. 1983;308:995–9.

    Article  CAS  PubMed  Google Scholar 

  47. Hocking MP, Davis GL, Franzini DA, et al. Long-term consequences after jejunoileal bypass for morbid obesity. Dig Dis Sci. 1998;43:2493–9.

    Article  CAS  PubMed  Google Scholar 

  48. Antal SC. Prevention and reversal of liver damage following biliopancreatic diversion for obesity. Obes Surg. 1994;4:285–90.

    Article  CAS  PubMed  Google Scholar 

  49. Castillo J, Fábrega E, Escalante CF, et al. Liver transplantation in a case of steatohepatitis and subacute hepatic failure after biliopancreatic diversion for morbid obesity. Obes Surg. 2001;11:640–2.

    Article  CAS  PubMed  Google Scholar 

  50. Cotler SJ, Vitello JM, Guzman G, et al. Hepatic decompensation after gastric bypass surgery for severe obesity. Dig Dis Sci. 2004;49:1563–8.

    Article  PubMed  Google Scholar 

  51. Eilenberg M, Langer FB, Beer A, et al. Significant liver-related morbidity after bariatric surgery and its reversal—a case series. Obes Surg. 2018;28:812–9.

    Article  PubMed  Google Scholar 

  52. Moize V, Geliebter A, Gluck ME, et al. Obese patients have inadequate protein intake related to protein intolerance up to 1 year following Roux- en-Y gastric bypass. Obes Surg. 2003;13:23–8.

    Article  PubMed  Google Scholar 

  53. Odstrcil EA, Martinez JG, Santa Ana CA, et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92:704–13.

    Article  CAS  PubMed  Google Scholar 

  54. Anand AC. Nutrition and muscle in cirrhosis. J Clin Exp Hepatol. 2017;7:340–57.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Barker KB, Palekar NA, Bowers SP, et al. Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery. Am J Gastroenterol. 2006;101(2):368–73.

    Article  PubMed  Google Scholar 

  56. Csendes A, Smok G, Burgos AM. Histological findings in the liver before and after gastric bypass. Obes Surg. 2006;16(5):607–11.

    Article  PubMed  Google Scholar 

  57. Mathurin P, Hollebecque A, Arnalsteen L, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009;137(2):532–40.

    Article  CAS  PubMed  Google Scholar 

  58. Kral JG, Thung SN, Biron S, et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery. 2004;135(1):48–58.

    Article  PubMed  Google Scholar 

  59. Stratopoulos C, Papakonstantinou A, Terzis I, et al. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg. 2005;15(8):1154–60.

    Article  PubMed  Google Scholar 

  60. Singh T, Kochhar GS, Goh GB, et al. Safety and efficacy of bariatric surgery in patients with advanced fibrosis. Int J Obes. 2017;41:443–9.

    Article  CAS  Google Scholar 

  61. Rebibo L, Gerin O, Verhaeghe P, et al. Laparoscopic sleeve gastrectomy in patients with NASH-related cirrhosis: a case-matched study. Surg Obes Relat Dis. 2014;10:405–10.

    Article  PubMed  Google Scholar 

  62. Jan A, Narwaria M, Mahawar KK. A systematic review of bariatric surgery in patients with liver cirrhosis. Obes Surg. 2015;25(8):1518–26.

    Article  PubMed  Google Scholar 

  63. Goh GB, Schauer PR, McCullough AJ. Considerations for bariatric surgery in patients with cirrhosis. World J Gastroenterol. 2018;24(28):3112–9.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.

    Article  PubMed  Google Scholar 

  65. Singh S, Dulai PS, Zarrinpar A, et al. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol. 2017;14:110–21.

    Article  CAS  PubMed  Google Scholar 

  66. Harper J, Zisman T. Interaction of obesity and inflammatory bowel disease. World J Gastroenterol. 2016;22:7868–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Steed H, Walsh S, Reynolds N. A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland. Obes Facts. 2009;2:370–2.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Causey MW, Johnson EK, Miller S, et al. The impact of obesity on outcomes following major surgery for Crohn’s disease: an American College of Surgeons National Surgical Quality Improvement Program assessment. Dis Colon Rectum. 2011;54:1488–95.

    Article  PubMed  Google Scholar 

  69. Ungar B, Kopylov U, Goitein D, et al. Severe and morbid obesity in Crohn’s disease patients: prevalence and disease associations. Digestion. 2013;88:26–32.

    Article  PubMed  Google Scholar 

  70. Moran GW, Dubeau MF, Kaplan GG, et al. The increasing weight of Crohn’s disease subjects in clinical trials: a hypothesis-generatings time-trend analysis. Inflamm Bowel Dis. 2013;19:2949–56.

    Article  PubMed  Google Scholar 

  71. Hemminki K, Li X, Sundquist J, Sundquist K. Risk of asthma and autoimmune diseases and related conditions in patients hospitalized for obesity. Ann Med. 2012;44:289–95.

    Article  PubMed  Google Scholar 

  72. Harpsøe MC, Basit S, Andersson M, et al. Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort. Int J Epidemiol. 2014;43:843–55.

    Article  PubMed  Google Scholar 

  73. Khalili H, Ananthakrishnan AN, Konijeti GG, et al. Measures of obesity and risk of Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2015;21:361–8.

    Article  PubMed  Google Scholar 

  74. Chan SS, Luben R, Olsen A, et al. Body mass index and the risk for Crohn’s disease and ulcerative colitis: data from a European prospective cohort study (the IBD in EPIC study). Am J Gastroenterol. 2013;108:575–82.

    Article  PubMed  Google Scholar 

  75. Bhalme M, Sharma A, Keld R, et al. Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn’s disease? Eur J Gastroenterol Hepatol. 2013;25:543–9.

    Article  CAS  PubMed  Google Scholar 

  76. Singh S, Proudfoot J, Xu R, Sandborn WJ. Obesity and response to infliximab in patients with inflammatory bowel diseases: pooled analysis of individual participant data from clinical trials. Am J Gastroenterol. 2018;113:883–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. The GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.

    Article  Google Scholar 

  78. Braga Neto MB, Gregory M, Piovezani Ramos GP, et al. De-novo inflammatory bowel disease after bariatric surgery: a large case series. J Crohns Colitis. 2017;12:452–7.

    Article  Google Scholar 

  79. Ungaro R, Fausel R, Chanq HL, et al. Bariatric surgery is associated with increased risk of new-onset inflammatory bowel disease: case series and national database study. Aliment Pharmacol Ther. 2018;47:1126–34.

    Article  CAS  PubMed  Google Scholar 

  80. Bastos ELS, Liberatore AMA, Tedesco RC, Koh IHJ. Gut microbiota imbalance can be associated with non-malabsorptive small bowel shortening regardless of blind loop. Obes Surg. 2018;29:369. https://doi.org/10.1007/s11695-018-3540-1.

    Article  Google Scholar 

  81. Ahn LB, Huang CS, Forse RA, et al. Crohn’s disease after gastric bypass surgery for morbid obesity: is there an association? Inflamm Bowel Dis. 2005;11:622–4.

    Article  PubMed  Google Scholar 

  82. Cañete F, Mañosa M, Clos A, et al. Review article: the relationship between obesity, bariatric surgery, and inflammatory bowel disease. Aliment Pharmacol Ther. 2018;48(8):807–16.

    Article  PubMed  Google Scholar 

  83. Bl K, Sonpal N, Schneider J, et al. Obesity/bariatric surgery and Crohn’s disease. J Clin Gastroenterol. 2018;52:50–4.

    Article  Google Scholar 

  84. Sharma P, McCarty TR, Niei B. Impact of bariatric surgery on outcomes of patients with inflammatory bowel disease: a nationwide inpatient sample analysis, 2004–2014. Obes Surg. 2018;28:1015–24.

    Article  PubMed  Google Scholar 

  85. Bazerbachi F, Sawas T, Vargas EJ, et al. Bariatric surgery is acceptably safe in obese inflammatory bowel disease patients: analysis of the Nationwide inpatient sample. Obes Surg. 2018;28:1007–14.

    Article  PubMed  Google Scholar 

  86. Keidar A, Hazan D, Sadot E, et al. The role of bariatric surgery in morbidly obese patients with inflammatory bowel disease. Surg Obes Relat Dis. 2015;11:132–6.

    Article  PubMed  Google Scholar 

  87. Colombo F, Rizzi A, Ferrari C, et al. Bariatric surgery in patients with inflammatory bowel disease: an accessible path? Report of a case series and review of the literature. J Crohns Colitis. 2015;9:185–90.

    Article  PubMed  Google Scholar 

  88. Aminian A, Andalib A, Ver MR, et al. Outcomes of bariatric surgery in patients with inflammatory bowel disease. Obes Surg. 2016;6:1189–90.

    Google Scholar 

  89. Lascano CA, Soto F, Carrodeguas L, et al. Management of ulcerative colitis in the morbidly obese patient: is bariatric surgery indicated. Obes Surg. 2006;16:783–6.

    Article  PubMed  Google Scholar 

  90. Tenorio-Jiménez C, Manzano-García G, Prior-Sánchez I, et al. Bariatric surgery in inflammatory bowel disease: case report and review of the literature. Nutr Hosp. 2013;28:958–60.

    PubMed  Google Scholar 

  91. Cottam D, Mattar S, Barinas E. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004;14:589–600.

    Article  PubMed  Google Scholar 

  92. Knoll G, Cockfield S, Blydt-Hansen T, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005;173(10):1181–4.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Kasiske BL, Cangro CB, Hariharan S, et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant. 2001;1(suppl 2):3–95.

    PubMed  Google Scholar 

  94. Abramowicz D, Cochat P, Claas FH, et al. European renal best practice guideline on kidney donor and recipient evaluation and perioperative care. Nephrol Dial Transplant. 2015;30(11):1790–7.

    Article  PubMed  Google Scholar 

  95. Tsochatzis E, Coilly A, Nadalin S, et al. International liver transplantation consensus statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation. Transplantation. 2019;103(1):45–56.

    Article  PubMed  Google Scholar 

  96. Khoraki J, Katz MG, Funk LM, et al. Feasibility and outcomes of laparoscopic sleeve gastrectomy after solid organ transplantation. Surg Obes Relat Dis. 2015;12:75–83.

    Article  PubMed  Google Scholar 

  97. Elli EF, Gonzalez-Heredia R, Sanchez-Johnsen L, et al. Sleeve gastrectomy surgery in obese patients post-organ transplantation. Surg Obes Relat Dis. 2016;12:528–34.

    Article  PubMed  Google Scholar 

  98. Yemini R, Nesher E, Winkler J, et al. Bariatric surgery in solid organ transplant patients: long-term follow-up results of outcome, safety, and effect on immunosuppression. Am J Transplant. 2018;18(11):2772–80.

    Article  PubMed  Google Scholar 

  99. Aalten J, Christiaans MH, de Fijter H, et al. The influence of obesity on short- and long-term graft and patient survival after renal transplantation. Transpl Int. 2006;19(11):901–7.

    Article  PubMed  Google Scholar 

  100. Cacciola RA, Pujar K, Ilham MA, et al. Effect of degree of obesity on renal transplant outcome. Transplant Proc. 2008;40(10):3408–12.

    Article  CAS  PubMed  Google Scholar 

  101. Lynch RJ, Ranney DN, Shijie C, et al. Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg. 2009;250(6):1014–20.

    Article  PubMed  Google Scholar 

  102. Molnar MZ, Kovesdy CP, Mucsi I, et al. Higher recipient body mass index is associated with post-transplant delayed kidney graft function. Kidney Int. 2011;80(2):218–24.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Hoogeveen EK, Aalten J, Rothman KJ, et al. Effect of obesity on the outcome of kidney transplantation: a 20-year follow-up. Transplantation. 2011;91(8):869–74.

    Article  PubMed  Google Scholar 

  104. Cannon RM, Jones CM, Hughes MG, et al. The impact of recipient obesity on outcomes after renal transplantation. Ann Surg. 2013;257(5):978–84.

    Article  PubMed  Google Scholar 

  105. Nicoletto BB, Fonseca NKO, Manfro RC, et al. Effects of obesity on kidney transplantation outcomes: a systematic review and meta-analysis. Transplantation. 2014;98(2):167–76.

    Article  PubMed  Google Scholar 

  106. McCloskey OM, Devine PA, Courtney AE, et al. Is big bad or bearable? Long-term renal transplant outcomes in obese recipients. QJM. 2018;111(6):365–71.

    Article  CAS  PubMed  Google Scholar 

  107. Hill CJ, Courtney AE, Cardwell CR, et al. Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis. Nephrol Dial Transplant. 2015;30:1403–11.

    Article  PubMed  Google Scholar 

  108. Al-Bahri S, Fakhry TK, Gonzalvo JP, et al. Bariatric surgery as a bridge to renal transplantation in patients with end-stage renal disease. Obes Surg. 2017;27(11):2951–5.

    Article  PubMed  Google Scholar 

  109. Lin MY, Tavakol MM, Sarin A, et al. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis. 2013;9(5):653–8.

    Article  PubMed  Google Scholar 

  110. Freeman CM, Woodle ES, Shi J, et al. Addressing morbid obesity as a barrier to renal transplantation with laparoscopic sleeve gastrectomy. Am J Transplant. 2015;15(5):1360–8.

    Article  CAS  PubMed  Google Scholar 

  111. Kienzl-Wagner K, Weissenbacher A, Gehwolf P, et al. Laparoscopic sleeve gastrectomy: gateway to kidney transplantation. Surg Obes Relat Dis. 2017;13(6):909–15.

    Article  PubMed  Google Scholar 

  112. Dziodzio T, Biebl M, Öllinger R, et al. The role of bariatric surgery in abdominal organ transplantation-the next big challenge? Obes Surg. 2017;27:2696–706.

    Article  PubMed  Google Scholar 

  113. Modanlou KA, Muthyala U, Xiao H, et al. Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation. 2009;87(8):1167–73.

    Article  PubMed  PubMed Central  Google Scholar 

  114. Szomstein S, Rojas R, Rosenthal RJ. Outcomes of laparoscopic bariatric surgery after renal transplant. Obes Surg. 2010;20(3):383–5.

    Article  PubMed  Google Scholar 

  115. Golomb I, Winkler J, Ben-Yakov A, et al. Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation. Am J Transplant. 2014;14(10):2384–90.

    Article  CAS  PubMed  Google Scholar 

  116. Chmura A, Ziemiański P, Lisik W, et al. Improvement of graft function following Roux-en-Y gastric bypass surgery in a morbidly obese kidney recipient: a case report and literature review. Ann Transplant. 2014;19:639–42.

    Article  PubMed  Google Scholar 

  117. Khoraki J, Katz MG, Funk LM, et al. Feasibility and outcomes of laparoscopic sleeve gastrectomy after solid organ transplantation. Surg Obes Relat Dis. 2016;12:75–83.

    Article  PubMed  Google Scholar 

  118. Osseis M, Lazzati A, Salloum C, et al. Sleeve gastrectomy after liver transplantation: feasibility and outcomes. Obes Surg. 2018;28(1):242–8.

    Article  PubMed  Google Scholar 

  119. Viscido G, Gorodner V, Signorini FJ, et al. Sleeve gastrectomy after renal transplantation. Obes Surg. 2018;28(6):1587–94.

    Article  PubMed  Google Scholar 

  120. Bonner K, Heimbach JK. Obesity management in the liver transplant recipient: the role of bariatric surgery. Curr Opin Organ Transplant. 2018;23:244–9.

    Article  PubMed  Google Scholar 

  121. Nair S, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology. 2002;35:105–9.

    Article  PubMed  Google Scholar 

  122. Leonard J, Heimbach JK, Malinchoc M, et al. The impact of obesity on long-term outcomes in liver transplant recipients: results of the NIDDK liver transplant database. Am J Transplant. 2008;8:667–72.

    Article  CAS  PubMed  Google Scholar 

  123. Dick AA, Spitzer AL, Seifert CF, et al. Liver transplantation at the extremes of the body mass index. Liver Transpl. 2009;15:968–77.

    Article  PubMed  Google Scholar 

  124. Perez-Protto SE, Quintini C, Reynolds LF, et al. Comparable graft and patient survival in lean and obese liver transplant recipients. Liver Transpl. 2013;19:907–15.

    Article  PubMed  Google Scholar 

  125. Orci LA, Majno PE, Berney T, et al. The impact of wait list body mass index changes on the outcome after liver transplantation. Transpl Int. 2013;26:170–6.

    Article  PubMed  Google Scholar 

  126. Watt KD, Pedersen RA, Kremers WK, et al. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow up study. Am J Transplant. 2010;10:1420–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Barone M, Viggiani MT, Avolio AW, et al. Obesity as predictor of postoperative outcomes in liver transplant candidates: review of the literature and future perspectives. Dig Liver Dis. 2017;49:957–66.

    Article  PubMed  Google Scholar 

  128. Adams LA, Arauz O, Angus PW, et al. Australian New Zealand liver transplant study group. Additive impact of pre-liver transplant metabolic factors on survival post-liver transplant. J Gastroenterol Hepatol. 2016;31(5):1016–24.

    Article  PubMed  Google Scholar 

  129. Lazzati A, Iannelli A, Schneck A-S, et al. Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery. Obes Surg. 2014;25:134–42.

    Article  Google Scholar 

  130. Nassif GB, Salloum C, Paolino L, et al. Laparoscopic sleeve gastrectomy after orthotopic liver transplantation, video reported. Obes Surg. 2019;29(4):1436–8.

    Article  Google Scholar 

  131. Nesher E, Mor E, Shlomai A, et al. Simultaneous liver transplantation and sleeve gastrectomy: prohibitive combination or a necessity? Obes Surg. 2017;27:1387–90.

    Article  PubMed  Google Scholar 

  132. Heimbach JK, Watt KD, Poterucha JJ, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant. 2013;13:363–8.

    Article  CAS  PubMed  Google Scholar 

  133. Tariciotti L, D’Ugo S, Manzia TM, et al. Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: first European case-report. Int J Surg Case Rep. 2016;28:38–41.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastrointestinal Surgery, Marilia Medical School, Marilia, Brazil

    Eduardo Lemos De Souza Bastos

  2. Gastro Obeso Center, Advanced Institute for Metabolic Optimization, Sao Paulo, Brazil

    Eduardo Lemos De Souza Bastos

  3. Bariatric Surgery, Gastro Obeso Center, Sao Paulo, Brazil

    Almino Ramos Cardoso

Authors
  1. Eduardo Lemos De Souza Bastos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Almino Ramos Cardoso
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Surgery, Sacré-Coeur Hospital, Montréal, QC, Canada

    Michel Gagner

  2. Bariatric Surgery, Gastro Obeso Center, Sao Paulo, Brazil

    Almino Ramos Cardoso

  3. Diagnomed, University of Buenos Aires, Buenos Aires, Argentina

    Mariano Palermo

  4. Emirates Specialty Hospital, Dubai, United Arab Emirates

    Patrick Noel

  5. CHU Montpellier, Saint Gely du Fesc, France

    David Nocca

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bastos, E.L.D.S., Cardoso, A.R. (2020). Special Indications: Cirrhosis, Inflammatory Bowel Disease, and Organ Transplantation. In: Gagner, M., Cardoso, A., Palermo, M., Noel, P., Nocca, D. (eds) The Perfect Sleeve Gastrectomy. Springer, Cham. https://doi.org/10.1007/978-3-030-28936-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-28936-2_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-28935-5

  • Online ISBN: 978-3-030-28936-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation